Medicenna Therapeutics Corp
(MDNAF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,658 | -18,878 | -8,491 | -4,908 | -2,129 |
| Depreciation Amortization | 4 | 3 | 2 | 2 | 1 |
| Other Working Capital | 689 | 549 | 1,148 | 630 | 283 |
| Other Operating Activity | 264 | 6,272 | -1,042 | -1,231 | -734 |
| Operating Cash Flow | $-1,701 | $-12,054 | $-8,383 | $-5,507 | $-2,580 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-23 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15,269 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $15,269 | $N/A | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 80 | -262 | -311 | -388 | -382 |
| Beginning Cash Position | 12,409 | 24,905 | 24,673 | 25,039 | 24,989 |
| End Cash Position | 26,034 | 12,589 | 15,979 | 19,145 | 22,028 |
| Net Cash Flow | $13,625 | $-12,316 | $-8,694 | $-5,895 | $-2,961 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,701 | -12,054 | -8,383 | -5,507 | -2,580 |
| Capital Expenditure | -23 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -1,724 | -12,054 | -8,383 | -5,507 | -2,580 |